ArticleAndrology2026
Dynamic Landscape of H3K4me3 and H3K27me3 Modification During Postnatal Leydig Cell Fate Determination.
Article in Andrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- YAP/TEAD complex restricts H3K27ac deposition to suppress testosterone synthesis in adult Leydig cells.Histochemistry and cell biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundHistone methylation plays a crucial role in regulating chromatin architecture and gene expression during spermatogenesis. H3K4me3 is enriched at the transcription start sites of active genes, whereas H3K27me3 is deposited on chromatin to confer transcriptional repression. However, the dynamics of H3K4me3 and H3K27me3 modifications in the differentiation of postnatal Leydig cells remain poorly characterized.
objectivesThe purpose of this study was to elucidate the dynamics of H3K4me3 and H3K27me3 modifications in the differentiation of postnatal Leydig cells.
methodsThrough an integrated analysis of single-cell RNA-seq (scRNA-seq), cleavage under targets and tagmentation sequencing (CUT&Tag-seq), bulk RNA-seq, and immunohistochemistry across different developmental stages of mouse Leydig cells, we mapped the stage-specific landscapes of H3K4me3 and H3K27me3.
resultsOur results demonstrate that during progenitor to immature Leydig cell differentiation, H3K4me3 levels exhibited a diphasic fluctuation pattern (first decreasing and then increasing), contrasting with the progressive accumulation of H3K27me3. In progenitor Leydig cells, the resolution of bivalent chromatin domains (accounting for 24.5% of promoters) helps balance cell proliferation and differentiation. Strikingly, steroidogenic genes such as Star, Cyp17a1, and Hsd17b3 are exclusively regulated by H3K4me3 and lack H3K27me3 marking. In terminally differentiated adult Leydig cells, H3K4me3 sustains the steroidogenic capacity by activating transcription factors (such as Gata6, Cebpb, Nr1d1) and maturation markers (including Hsd17b3, Insl3, Sult1e1), while H3K27me3 permanently silences proliferation-related networks (such as Ccna2, Mki67, Ccnd1) to eliminate the self-renewal potential of these cells. DISCUSSION AND
conclusionOur work identifies an H3K4me3/H3K27me3-transcription factors (TFs)-target gene axis as a central regulatory mechanism governing postnatal Leydig cell differentiation. This discovery clarifies how this axis endows Leydig cells with steroidogenic potential while suppressing stemness properties.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.